SCHEMBL2638820

SCHEMBL2638820

CN(C)c1cccc(C(=O)NC23CC4CC(CC(N)(C4)C2)C3)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.56
FAAH O00519 4/20 0.51
KMT2A Q03164 3/20 0.50
CNR2 P34972 3/20 0.50
MEN1 O00255 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
ATM Q13315 1/20 0.46
RAB9A P51151 2/20 0.46
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
GFER P55789 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
POLB P06746 2/20 0.44
TSHR P16473 1/20 0.44
PBK Q96KB5 1/20 0.44
LMNA P02545 1/20 0.44
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2638816 0.87 USP2 (0.59) USP2FAAHKMT2ACNR2MEN1
SCHEMBL3378216 0.86 POLB (0.52) FAAHKMT2ACNR2MEN1RAB9A
SCHEMBL3376422 0.83 FAAH (0.74) FAAHKMT2ACNR2MEN1L3MBTL1
SCHEMBL3377753 0.82 FAAH (0.54) FAAHKMT2ACNR2MEN1L3MBTL1
SCHEMBL1578168 0.82 GRM5 (0.55) FAAHKMT2ACNR2MEN1L3MBTL1
SCHEMBL2638888 0.82 CNR2 (0.76) FAAHKMT2ACNR2MEN1L3MBTL1
SCHEMBL2639172 0.81 FAAH (0.70) FAAHCNR2L3MBTL1ATMKDM4E
SCHEMBL1578322 0.81 GRM5 (0.55) USP2FAAHKMT2ACNR2MEN1
Hydrochloric Acid SCHEMBL30685078 0.81 FAAH (0.54) FAAHKMT2ACNR2MEN1L3MBTL1
SCHEMBL2637894 0.80 FAAH (0.51) FAAHKMT2ACNR2MEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP claimed
JP-2011529057-A 2011-12-01 JP claimed
WO-2010011570-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 WO claimed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US claimed
EP-2310356-B1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME LUNDBECK & CO AS H (DK) 2013-08-14 EP disclosed
US-8389519-B2 Adamantyl diamide derivatives and uses of same H. LUNDBECK A/S (DK) 2013-03-05 US disclosed
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2012-10-25 US disclosed
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME H. LUNDBECK A/S (DK) 2010-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120270873-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, PDE3B, ADM2 USP2 2499/4885FAAH 2836/4885KMT2A 3173/4885
US-20100022546-A1 ADAMANTYL DIAMIDE DERIVATIVES AND USES OF SAME QDPR, ADM2, PDE3B USP2 2524/4885FAAH 2906/4885KMT2A 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.